2015
Quetiapine in children and adolescents with subaverage IQ
Jou R, Handen B, Hardan A. Quetiapine in children and adolescents with subaverage IQ. Journal Of Pediatric Neurology 2015, 03: 035-039. DOI: 10.1055/s-0035-1557235.Peer-Reviewed Original ResearchTolerability of quetiapineSpecialized outpatient clinicConners' Parent Rating ScaleExperienced sedationConcomitant medicationsAdverse eventsChart reviewOutpatient clinicRetrospective studyTreatment durationParent Rating ScaleSame caregiverHyperactivity subscaleQuetiapinePatientsRating ScaleMental retardationSubaverage IQMedicationsMaintenance periodChildrenAdolescentsSubscalesTolerabilitySedation
2005
Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental Disorders
Hardan A, Jou R, Handen B. Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental Disorders. Journal Of Autism And Developmental Disorders 2005, 35: 387-391. PMID: 16119479, DOI: 10.1007/s10803-005-3306-1.Peer-Reviewed Original ResearchConceptsRetrospective studyPervasive developmental disorderTolerability of quetiapinePlacebo-controlled studyDevelopmental disordersAdverse eventsChart reviewConsecutive outpatientsTreatment terminationQuetiapineHyperactivity subscaleDevelopmental disabilitiesDisordersChildrenAdolescentsParent scaleTolerabilitySedationPatientsOutpatientsClinicRespondersRetrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental Disorders
Jou R, Handen B, Hardan A. Retrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental Disorders. Journal Of Child And Adolescent Psychopharmacology 2005, 15: 325-330. PMID: 15910217, DOI: 10.1089/cap.2005.15.325.Peer-Reviewed Original ResearchConceptsConners' Parent Rating ScalePervasive developmental disorderConcomitant medicationsClinical Global Impression ScaleTolerability of atomoxetinePlacebo-controlled studyGlobal Impression ScaleGlobal improvement itemSevere mood swingsDevelopmental disordersCPRS subscaleMost patientsClinic registryRetrospective studyImpression ScaleTreatment responseTreatment doseClinical informationPatientsAtomoxetineSecondary symptomsParent Rating ScaleMood swingsRating ScaleRetrospective assessment
2004
A Retrospective Assessment of Topiramate in Children and Adolescents with Pervasive Developmental Disorders
Hardan A, Jou R, Handen B. A Retrospective Assessment of Topiramate in Children and Adolescents with Pervasive Developmental Disorders. Journal Of Child And Adolescent Psychopharmacology 2004, 14: 426-432. PMID: 15650499, DOI: 10.1089/cap.2004.14.426.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderOpen-label retrospective studyClinical Global Impression ScalePlacebo-controlled studyRetrospective chart reviewNovel antiepileptic drugGlobal Impression ScaleGlobal improvement itemDevelopmental disordersOpenlabel studyConcomitant medicationsChart reviewSkin rashAdjunctive treatmentSeizure disorderAntiepileptic drugsOutpatient clinicRetrospective studyMean doseImpression ScaleMedical recordsTreatment responsePatientsSide effectsTreatment duration
2003
Triple diagnosis: dual diagnosis and HIV disease, part 2.
Douaihy A, Jou R, Gorske T, Salloum I. Triple diagnosis: dual diagnosis and HIV disease, part 2. The AIDS Reader 2003, 13: 375-82. PMID: 14524322.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnti-HIV AgentsAttitude to HealthContinuity of Patient CareCooperative BehaviorDiagnosis, Dual (Psychiatry)Drug InteractionsDrug Therapy, CombinationHIV InfectionsHumansMental DisordersMethadoneModels, PsychologicalMotivationNeeds AssessmentPatient Care TeamPatient Education as TopicPsychopharmacologyPsychotherapyPsychotropic DrugsSafetySubstance-Related DisordersConceptsTriple diagnosisCare of patientsHIV diseaseSubstance use interventionsPatient readinessPsychopharmacologic managementPsychopharmacologic strategiesDual diagnosisPsychosocial needsPatient carePsychotherapeutic interventionsTreatment issuesDiagnosisMedical servicesCareUse interventionsPatientsPsychotherapeutic modalitiesInterventionMore researchDiseasePsychoeducation